ArticleHemaSphere2024
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience.
Abstract read
In one paragraph
Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.British journal of haematology · 2026Observational
- No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.Blood advances · 2026Article
- Beyond mechanisms: toward patient-centered choices in BTKi-venetoclax fixed-duration therapy for CLL.Leukemia · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Idanna InnocentiDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Antonio MoscaSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche Università Cattolica del Sacro Cuore Rome Italy.
Annamaria TomassoSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche Università Cattolica del Sacro Cuore Rome Italy.ORCID 0009-0005-5361-7463
Andrea GalitziaHematology and Stem Cell Transplantation Unit Ospedale San Francesco Nuoro Italy.
Lydia ScarfòStrategic Research Program on CLL IRCSS Ospedale San Raffaele Milano Italy.
Francesca MorelliHematology University of Florence Florence Italy.
Eugenio GalliDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Francesca MartiniStrategic Research Program on CLL IRCSS Ospedale San Raffaele Milano Italy.
Eugenio SangiorgiDipartimento di Scienze della Vita e Sanità Pubblica, Sezione di Medicina Genomica Università Cattolica del Sacro Cuore Rome Italy.
Roberta LaureanaDivision of Haematology University of Tor Vergata Rome Italy.
Giulia BenintendeDepartment of Medicine 5, Haematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Universitätsklinikum Erlangen Germany.
Veronica MattielloHematology Unit Fondazione IRCCS Ca' Granda Policlinico Milano Italy.
Sabrina ChiriuDepartment of Medical Sciences and Public Health University of Cagliari Cagliari Italy.
Maria I Del PrincipeDivision of Haematology University of Tor Vergata Rome Italy.
Giulia ZamprognaDepartment of Hematology Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milano Italy.
Massimo GentileHematology Section Cosenza Hospital Cosenza Italy.
Enrica A MartinoHematology Section Cosenza Hospital Cosenza Italy.
Emilia CappelloDipartimento di Medicina Molecolare Università di Pavia Pavia Italy.
Maria C MontalbanoDepartment of Molecular Biotechnology and Health Sciences University of Torino and Division of Hematology, University Hospital (A.O.U.) Città della Salute e della Scienza di Torino Torino Italy.
Giuliana FarinaHematology and Medical Oncology, AORN Sant'Anna e San Sebastiano Caserta Italy.
Vanessa InnaoUOC di Ematologia, Azienda Ospedaliera di rilievo nazionale di alta specializzazione ARNAS - Garibaldi di Catania Catania Italy.
Luca StirparoSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche Università Cattolica del Sacro Cuore Rome Italy.
Caterina PattiDivisione di Oncoematologia, Azienda Villa Sofia Cervello Palermo Italy.
Paolo SportolettiDepartment of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato Oncologica (CREO) University of Perugia Perugia Italy.
Alberto FresaDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Gioacchino CataniaDivision of Hematology, Hospital Saints (A. O. SS) Antonio e Biagio and Cesare Arrigo Alessandria Italy.
Marta CosciaDepartment of Molecular Biotechnology and Health Sciences University of Torino and Division of Hematology, University Hospital (A.O.U.) Città della Salute e della Scienza di Torino Torino Italy.
Silvia BellesiDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Alessandra TedeschiDepartment of Hematology Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda Milano Italy.
Alessandro SannaHematology, Department of Oncology AOU Careggi Firenze Italy.
Andrea VisentinHematology and Clinical Immunology Unit, Department of Medicine - DIMED University of Padua, School of Medicine Padova Italy.
Francesco AutoreDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Raffaella PasqualeSOC Clinica Ematologia Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) Udine Italy.
Livio TrentinHematology and Clinical Immunology Unit, Department of Medicine - DIMED University of Padua, School of Medicine Padova Italy.
Marzia VarettoniDivisione di Ematologia Fondazione IRCCS Policlinico San Matteo Pavia Italy.
Paolo GhiaStrategic Research Program on CLL IRCSS Ospedale San Raffaele Milano Italy.ORCID 0000-0003-3750-7342
Roberta MurruHematology and Stem Cell Transplantation Unit Ospedale Oncologico Armando Businco, ARNAS G. Brotzu Cagliari Italy.
Luca LaurentiDipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.